Kiyoshi MaedaMasatsune ShibutaniHiroshi OtaniTatsunari FukuokaYasuhito IsekiShinji MatsutaniHisashi NagaharaToru InoueAkiko TachimoriTakafumi NishiiYoshitaka MikiMasako HosonoMasaichi Ohira
Although acute toxicity during CRT with bevacizumab was minimal and postoperative complications do not seem to increase, the addition of bevacizumab apparently offers no clinically-significant benefit for patients with LARC.
Yukio MikiKiyoshi MaedaMakoto HosonoHisashi NagaharaKosei HirakawaYasuhiko ShimataniS. TsutsumiYukio Miki
Xin YuQiaoxuan WangWeiwei XiaoHui ChangZhifan ZengZhen-Hai LuXiaojun WuGong ChenZhizhong Z. PanDe-Sen WanPeirong DingYuanhong Gao
Giampietro GaspariniFrancesco TorinoTakayuki UenoStefano CascinuTeresa TroianiAlberto BallestreroRossana BerardiJunichi ShishidoAkihiko YoshizawaYukiko MoriSatoshi NagayamaPaola MorosiniMasakazu Toi
Christopher H. CraneCathy EngBarry W. FeigPrajnan DasJohn M. SkibberGeorge J. ChangRobert A. WolffSunil KrishnanStanley R. HamiltonNora A. JanjanDipen M. MaruLee M. EllisMiguel A. Rodrı́guez-Bigas
Vaneja VelenikJanja OcvirkMaja Marolt MušičMatej BračkoFranc AnderluhIrena OblakIbrahim EdhemovićErik BreceljMateja KropivnikMirko Omejc